Wikisage, the free encyclopedia of the second generation, is digital heritage

Perampanel: Difference between revisions

From Wikisage
Jump to navigation Jump to search
(Created page with "<gallery>File:Perampanel_molecule_ball.png</gallery> <ref>http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/002434/WC500130815.pdf</ref><re...")
 
(refs)
 
(11 intermediate revisions by the same user not shown)
Line 1: Line 1:
<gallery>File:Perampanel_molecule_ball.png</gallery>
(Fycompa) is an AED
<ref>http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/002434/WC500130815.pdf</ref><references/>
<ref>[https://www.ncbi.nlm.nih.gov/pubmed/26370209 Perampanel: A Review in Drug-Resistant Epilepsy]</ref>
5′-(2-Cyanphenyl)-1′-phenyl-2,3′-bipyridinyl-6′(1′H)-on
<ref>http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-_Product_Information/human/002434/WC500130815.pdf</ref>
Perampanel was efficacious and well tolerated, despite the observation that the patient population exhibited characteristics of highly refractory [[epilepsy]]
 
<ref>http://n.neurology.org/content/suppl/2016/04/10/WNL.0000000000001930.DC3/french_950.pdf</ref>
 
==ATC==
 
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5
|colspan=2| <center><gallery>File:Perampanel_molecule_ball.png</gallery>
: [[wikipedia:perampanel|perampanel]]
<ref>[http://www.whocc.no/atc_ddd_index/?code=N03AX22 N03AX22]</ref></center>
|}
 
 
 
[http://onlinelibrary.wiley.com/doi/10.1111/epi.12212/full Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies]
 
 
{{wikidata|Q868658}}
 
{{refs}}
 
[[Category:Anticonvulsant]]

Latest revision as of 01:31, 7 May 2019